Literature DB >> 15254943

Assessing comorbidity in patients with Parkinson's disease.

Martine Visser1, Johan Marinus1, Jacobus J van Hilten1, Ruth G B Schipper1, Anne M Stiggelbout2.   

Abstract

The aim of this study was to assess the accuracy of an interview-based assessment of comorbidity, in patients with Parkinson's disease (PD). The Cumulative Illness Rating Scale-Geriatric (CIRS-G) was completed (1) in an interview with 31 PD patients and their caregivers, and (2) by reviewing the patient's medical charts from their general practitioners. Based on the interview, all patients had some comorbidity, 84% had one or more moderate comorbid diseases. The most frequently affected organ systems were "lower gastrointestinal" and "genitourinary". The mean +/- SD total score of the interview-based (chart-based) CIRS-G was 6.9 +/- 3.8 (7.6 +/- 3.5) with a mean of 4.3 +/- 1.9 (5.0 +/- 1.9) affected organ systems and a mean of 2.1 +/- 1.7 (2.3 +/- 1.6) organ systems with at least moderate comorbidity per patient. The agreement (intraclass correlation coefficients) between the interview-based and chart-based assessments for the six summary scores ranged from 0.69 to 0.81. The agreement for the 14 organ systems ranged from 0.13 to 1.00 (weighted kappa); 12 had a K(w) above 0.40 (moderate agreement). The comorbidity summary scores had a moderate correlation with age and disability. The interview-based assessment of the CIRS-G is easy to apply and is an accurate method to assess comorbidity in patients with PD. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254943     DOI: 10.1002/mds.20060

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study.

Authors:  Esther Cubo; Julián Benito-León; Carlos Coronell; Diana Armesto
Journal:  Neuroepidemiology       Date:  2012-01-06       Impact factor: 3.282

2.  Effects of Group, Individual, and Home Exercise in Persons With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Laurie A King; Jennifer Wilhelm; Yiyi Chen; Ron Blehm; John Nutt; Zunqiu Chen; Andrea Serdar; Fay B Horak
Journal:  J Neurol Phys Ther       Date:  2015-10       Impact factor: 3.649

Review 3.  Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Marian L Evatt
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

4.  Comorbidity and functional mobility in persons with Parkinson disease.

Authors:  Laurie A King; Kelsey C Priest; John Nutt; Yiyi Chen; Zunqiu Chen; Marsha Melnick; Fay Horak
Journal:  Arch Phys Med Rehabil       Date:  2014-08-04       Impact factor: 3.966

Review 5.  Parkinson disease and comorbid cerebrovascular disease.

Authors:  Wandana Nanhoe-Mahabier; Karlijn F de Laat; Jasper E Visser; Jan Zijlmans; Frank-Erik de Leeuw; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

6.  Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial.

Authors:  Esther Cubo; Alvaro Garcia-Bustillo; Alvar Arnaiz-Gonzalez; Jose Miguel Ramirez-Sanz; Jose Luis Garrido-Labrador; Florita Valiñas; Marta Allende; Jeronimo Javier Gonzalez-Bernal; Josefa Gonzalez-Santos; José Francisco Diez-Pastor; Maha Jahouh; Jana Arribas; Jose Trejo
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

7.  Experienced Respiratory Symptoms and the Impact on Daily Life from the Perspective of People with Parkinson's Disease: A Grounded Theory.

Authors:  Veerle A van de Wetering-van Dongen; Maarten J Nijkrake; Niek Koenders; Philip J van der Wees; Bastiaan R Bloem; Johanna G Kalf
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

8.  High rates of blood transfusion associated with Parkinson's disease.

Authors:  Shane Shahrestani; Julian Gendreau; Ali R Tafreshi; Nolan J Brown; Khashayar Dashtipour
Journal:  Neurol Sci       Date:  2022-05-02       Impact factor: 3.830

9.  Factors Associated with Low Body Mass Index in Huntington's Disease: A Spanish Multicenter Study of the European Huntington's Disease Registry.

Authors:  Esther Cubo; Jessica Rivadeneyra; Natividad Mariscal; Asunción Martinez; Diana Armesto; Rafael J Camara
Journal:  Mov Disord Clin Pract       Date:  2016-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.